SARS-CoV-2 Antigen Rapid Qualitative Test Type B

SARS-CoV-2 Antigen Rapid Qualitative Test Type A

Lp-PLA2 Rapid Quantitative Test

Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an enzyme that plays a role in the inflammation of blood vessels and is thought to help promote atherosclerosis. Biotime rapid quantitative test kit measures the amount or activity of Lp-PLA2 in the human blood.

Cys-C Rapid Quantitative Test

Serum Cystatin C(Cys-C) has been proposed as a marker of glomerular filtration rate(GFR). Serum creatinine (creatinine) is widely used to estimate the glomerular filtration rate, but its tubular secretion, dependence on muscle mass, alteration in some inflammatory diseases, and analytical interferences can limit its utility. Thus, Cys-C has been proposed as a novel biomarker of kidney function.

NGAL Rapid Quantitative Test

NGAL (neutrophil gelatinase-associated lipocalin, lipocalin-2, sidero- calin) is a novel biomarker for diagnosing acute kidney injury (AKI). Under normal conditions NGAL levels are low in urine and plasma Still, they rise sharply from basal levels in response to kidney injury to reach diagnostic levels within a very short time - as much as 24 hours or more before any signiﬁcant rise in serum creatinine.

CEA Rapid Quantitative Test

Carcinoembryonic antigen (CEA) is a protein normally found in very low levels in the blood of adults. The CEA blood level may be increased in certain types of cancer and non-cancerous (benign) conditions. A CEA test is most commonly used for colorectal cancer.

IL-6 Rapid Quantitative Test

IL-6 is a valuable biomarker for early detection and monitoring of inflammatory conditions, particularly in the context of bacterial infections and sepsis.

PROG Rapid Quantitative Test (Chemiluminescence Immunoassay)

PROG Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Progesterone (PROG) concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of reproductive hormones diseases.

BNP Rapid Quantitative Test (Chemiluminescence Immunoassay)

BNP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Brain natriuretic peptide (BNP) concentration in human plasma that contains EDTA anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.

Solutions

Covid-19 Solution

SARS-CoV-2 Antigen Rapid Test

SARS-CoV-2 Antigen Rapid Qualitative Test Type B